Referenser

[PICC-line]

1. Todd J: Peripherally Inserted Central Catheters and Their Use in IV Therapy. Br J Nursing 1999; 8(3):140-148
2. Moureau N, Poole S, Murdock MA, Gray SM, Semba CP: Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. Journal of Vascular & Interventional Radiology 2002; 13(10):1009-16
3. Todd J: Peripherally Inserted Central Catheters. Prof Nurse 1998; 13(5):297-302
4. Lindblad C, BARD Medical Systems: Personal Communication, 2002
5. Anonymous: Position Paper: Peripherally Inserted Central Catheters. J Intraven Nurs 1997; 20(4):172-174
6. Alexander M (ed): Infusion Nursing. Standards of Practice. 2000
7. Ryder MA: Peripherally inserted central venous catheters. Nurs Clin North Am 1993; 28(4):937-71
8. Gabriel J: Peripherally inserted central catheters: expanding UK nurses' practice. Br J Nurs 1996; 5(2):71-4
9. Andersson M: Personlig kommunikation, Bard Medical Systems Norden AB, 2008
10. Goodwin ML, Carlson I: The Peripherally Inserted Central Catheter. A Retrospective Look at Three years of Insertions. J Infus Nurs 1993; 16(2):92
11. Gabriel J: Care and management of peripherally inserted central catheters. Br J Nurs 1996; 5(10):594, 596-9
12. Philpot P, Griffiths V: The peripherally inserted central catheter. Nurs Stand 2003; 17(44):39-46; quiz 48-9
13. Harter C, Ostendorf T, Bach A, Egerer G, goldschmidt H, Ho AD: Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Center 2003; 11(12):790-4
14. Skiest DJ, Abbott M, Keiser P: Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate. Clin Infect Dis 2000; 30(6):949-52
15. Crowley J, Pereira J, Harris L, Becker C: Peripherally inserted central catheters: experience in 523 children. Radiology 1997; 204(3):617-21
16. Cowl CT, Weinstock JV, Al-Jurf A, Ephgrave K, Murray JA, Dillon K: Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr 2000; 19(4):237-43
17. Gonsalves CF, Eschelman DJ, Sullivan KL, DuBois N, Bonn J: Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement. Cardiovasc Intervent Radiol 2003; 26/2):123-7
18. Allen AW, Megargell JL, Brown DB, Lynch FC, Singh H, Singh Y, Waybill PN: Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol 2000; 11(10):1309-14
19. Parras F, Ena J, Bounza E, Guerrero MC, Boreno S, Galvez T, Cercenado E: Impact of an educational program for the prevention of colonization of intravascular catheters. Infect Control Hosp Epidemiol 1994; 15(4 Pt 1):239-42
20. Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, Sona CS, Buchman TG, Boyle WA, Polish LB, Fraser VJ: Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002; 30(1):59-64
21. Driscoll M, Buckenyer C, Spirk M, Molchany C: Inserting and maintaining peripherally inserted central catheters. Medsurg Nurs 1997; 6(6):350-3, 356-8
22. Centers for disease control and prevention, Guideline for Hand Hygiene in Health Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA hand Hygiene Task Force. MMWR Recomm Rep 2002; 51(16):1-45
23. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30(8):476-89
24. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP: Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168(2):400-7
25. Salzman MB, Isenberg HD, Rubin LG: Use of disinfectants to reduce microbial contanimation of hubs of vascular catheters. J Clin Microbiol 1993; 31(3):475-9
26. Do AN, Ray BJ, Banerjee SN, Illian AF, Barnett BJ, Pham MH, Hendricks KA, Jarvis WR: Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179(2):442-8
27. Bouza E, Munoz P, Lopez-Rodriguez J, Jesus Perez M, Rincon C, Martin Rabadan P, Sanchez C, Bastida E: A needless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hops Infect 2003; 54(4):279-87
28. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS: A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needless connector. J Hosp Infect 2003; 54(4):288-93
29. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS: A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect 2000; 45(2):165-8
30. Yebenes JC, Vidaur L, Serra-Prat M, Sirvent JM, Batlle J, Motje M, Bonet A, Palomar M: Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control 2004; 32(5):291-5
31. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF: The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985; 6(9):367-70
32. Maki DG, Botticelli JT, LeRoy ML, Thielke TS: Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours in safe and cost-effective. Jama 1987; 258(13):1777-81
33. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ: Intervenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987; 8(3):113-6
34. Hanna HA, Raad I: Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol 2001; 22(3):165-6
35. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, Richardson D, Umphrey JL, Whimbey E, Mansour G: Optimal frequency of changing intravenous administration sets: is it safe to prolog use beyond 72 hours? Infect Control Hosp Epidemiol 2001; 22(3):136-9
36. Hadaway LC: Flushing to reduce central catheter occlusions. Nursing 2000;30(10):74
37. Macklin D: What's physics got to do with it? A review of the physical principles of fluid administration. J Vasc Access Devices 1999; 4(2):7-11
38. Hadaway L: Personlig kommunikation, 2010
39. Douglas L, Aspin A, Jimmeson N, Lawrance V: Central venous access devices: review of practice. Paediatr Nurs 2009; 21(5):19-22
40. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad, II, Randolph A, Weinstein RA: Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-10):1-29
41. Sveriges Kommuner och Landsting: Förebygg infektioner vid centrala venösa infarter. Nationell satsning för ökad patientsäkerhet. Stockholm, Sveriges Kommuner och Landsting, 2008
42. Johnsson H: Personal communication. Edited by Strömberg M. Stockholm, 2005
43. Rooden CJ, Tesselaar ME, Osanto S, Rosendaal FR, Huisman MV: Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost 2005; 3(11):2409-19
44. Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER: Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial -- the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12(8):951-5
45. Reed T, Phillips S: Management of central venous catheter occlusions and repairs. J Intraven Nurs 1996; 19(6):289-94
46. Bona RD: Thrombotic compications of central venous catheters in cancer patients. Semin Thromb Hemost 1999; 25(2):147-55
47. Kovacs MJ, Kahn SR, Rodger M, Anderson DR, Andreou R, Mangel JE, Morrow B, Clement AM, Wells PS: A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007; 5(8):1650-3
48. Johnsson H: Personlig kommunikation, 2005
49. Ely EW, Hite RD, Baker AM, Johnson MM, Bowton DL, Haponik EF: Venous air embolism from central venous catheterization: a need for increased physician awareness. Crit Care Med 1999; 27(10):2113-7.
50. Macklin D: Removing a PICC. Am J Nurs 2000; 100(1):52-4.